Vitenskapelig artikkel

• Cornelia Schuster; Lars A. Akslen; Tomasz Stokowy et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (ekstern lenke)
• Cornelia Schuster; Hans Petter Eikesdal; Hanne Eknes Puntervoll et al. (2012). Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. (ekstern lenke)
• Cornelia Schuster; Lars A. Akslen; Oddbjørn Straume (2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (ekstern lenke)
• Cornelia Schuster; Lars Andreas Akslen; Oddbjørn Straume (2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (ekstern lenke)
• Elin Aamdal; Kari Dolven Jacobsen; Oddbjørn Straume et al. (2021). Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up. (ekstern lenke)
• Emilia Signe Hugdahl; Ingeborg M. Bachmann; Cornelia Schuster et al. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. (ekstern lenke)
• Rakel Brendsdal Forthun; Randi Hovland; Cornelia Schuster et al. (2019). ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab. (ekstern lenke)

Konferanseabstrakt

• Cornelia Schuster; Gro Gausdal; Bjørn Tore Gjertsen et al. (2018). Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma. (ekstern lenke)

Doktorgradsavhandling

• Cornelia Schuster; Oddbjørn Straume (2016). Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab. (ekstern lenke)

Vitenskapelig bokkapittel

• Hanna Dillekås; Cornelia Schuster; Kjersti Davidsen et al. (2022). The Role of the Microenvironment in Tumor Promoting Stress Responses. (ekstern lenke)
• Oddbjørn Straume; Cornelia Schuster (2017). The Tumor Microenvironment in Cutaneous Melanoma: Friend or Foe. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Kremena Petrova Trichkova; Franziska Stilla Maria Görtler; Line Bjørge et al. (2024). Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin